The immunoregulatory and fibrotic roles of activin A in allergic asthma

Clinical and Experimental Allergy

Volumn 45, Issue 10, 2015, Pages 1510-1522

  Hardy, C L ^a,b   Rolland, J M ^a,b   O'Hehir, R E ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR; FOLLISTATIN RELATED PROTEIN; INHIBIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; ACTIVIN;

AIRWAY REMODELING; ALLERGIC ASTHMA; HUMAN; IMMUNOREGULATION; INFLAMMATION; LUNG FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ASTHMA; IMMUNOLOGY; MOUSE; PATHOLOGY;

ACTIVINS; AIRWAY REMODELING; ANIMALS; ASTHMA; HUMANS; INFLAMMATION; MICE; PULMONARY FIBROSIS; SIGNAL TRANSDUCTION;

EID: 84941629106     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12561     Document Type: Review

References (95)

1. Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 2008; 8:193-204.
2. Holgate ST. Asthma: a simple concept but in reality a complex disease. Eur J Clin Invest 2011; 41(12):1339-52.
3. Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002; 3:715-20.
4. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004; 22:789-815.
5. Trevor JL, Deshane JS. Refractory asthma: mechanisms, targets, and therapy. Allergy 2014; 69:817-27.
6. Durrani SR, Viswanathan RK, Busse WW. What effect does asthma treatment have on airway remodeling? Current perspectives. J Allergy Clin Immunol 2011; 128:439-48; quiz 49-50.
7. Pohunek P, Warner JO, Turzikova J, Kudrmann J, Roche WR. Markers of eosinophilic inflammation and tissue re-modelling in children before clinically diagnosed bronchial asthma. Pediatr Allergy Immunol 2005; 16:43-51.
8. Willart MA, Deswarte K, Pouliot P et al. Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med 2012; 209:1505-17.
9. Alcorn JF, Rinaldi LM, Jaffe EF et al. Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease. Am J Respir Crit Care Med 2007; 176:974-82.
10. Batra V, Musani AI, Hastie AT et al. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 2004; 34:437-44.
11. Karagiannidis C, Hense G, Martin C et al. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma. J Allergy Clin Immunol 2006; 117:111-8.
12. Kariyawasam HH, Pegorier S, Barkans J et al. Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma. J Allergy Clin Immunol 2009; 124:454-62.
13. McMillan SJ, Xanthou G, Lloyd CM. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol 2005; 174:5774-80.
14. Nakao A, Miike S, Hatano M et al. Blockade of transforming growth factor beta/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity. J Exp Med 2000; 192:151-8.
15. Ohno I, Nitta Y, Yamauchi K et al. Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1996; 15:404-9.
16. Redington AE, Madden J, Frew AJ et al. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1997; 1:642-7.
17. Vignola AM, Chanez P, Chiappara G et al. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997; 156(2 Pt 1):591-9.
18. Hardy CL, Nguyen HA, Mohamud R et al. The activin A antagonist follistatin inhibits asthmatic airway remodelling. Thorax 2013; 68:9-18.
19. Hardy CL, O'Connor AE, Yao J et al. Follistatin is a candidate endogenous negative regulator of activin A in experimental allergic asthma. Clin Exp Allergy 2006; 36:941-50.
20. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113:685-700.
21. Harrison CA, Al-Musawi SL, Walton KL. Prodomains regulate the synthesis, extracellular localisation and activity of TGF-beta superfamily ligands. Growth Factors 2011; 29:174-86.
22. Harrison CA, Gray PC, Vale WW, Robertson DM. Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 2005; 16:73-8.
23. Tsuchida K, Nakatani M, Hitachi K et al. Activin signaling as an emerging target for therapeutic interventions. Cell Commun Signal 2009; 7:15.
24. Hedger MP, Winnall WR, Phillips DJ, de Kretser DM. The regulation and functions of activin and follistatin in inflammation and immunity. Vitam Horm 2011; 85:255-97.
25. Matzuk MM, Kumar TR, Vassalli A et al. Functional analysis of activins during mammalian development. Nature 1995; 374:354-6.
26. Vassalli A, Matzuk MM, Gardner HA, Lee KF, Jaenisch R. Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev 1994; 8:414-27.
27. Li S, Shimono C, Norioka N et al. Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity. J Biol Chem 2010; 285:36645-55.
28. ten Dijke P, Hill CS. New insights into TGF-beta-Smad signalling. Trends Biochem Sci 2004; 29:265-73.
29. Onichtchouk D, Chen YG, Dosch R et al. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 1999; 401:480-5.
30. Gray PC, Harrison CA, Vale W. Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc Natl Acad Sci USA 2003; 100:5193-8.
31. Wu G, Chen YG, Ozdamar B et al. Structural basis of Smad2 recognition by the Smad anchor for receptor activation. Science 2000; 287:92-7.
32. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 1998; 95:779-91.
33. Sflomos G, Kostaras E, Panopoulou E et al. ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBIN. J Cell Sci 2011; 124(Pt 19):3209-22.
34. Yan X, Liu Z, Chen Y. Regulation of TGF-beta signaling by Smad7. Acta Biochim Biophys Sin 2009; 41:263-72.
35. Yan X, Lin Z, Chen F et al. Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. J Biol Chem 2009; 284:30097-104.
36. Harrington AE, Morris-Triggs SA, Ruotolo BT, Robinson CV, Ohnuma S, Hyvonen M. Structural basis for the inhibition of activin signalling by follistatin. EMBO J 2006; 25:1035-45.
37. Thompson TB, Lerch TF, Cook RW, Woodruff TK, Jardetzky TS. The structure of the follistatin: activin complex reveals antagonism of both type I and type II receptor binding. Dev Cell 2005; 9:535-43.
38. Nogai H, Rosowski M, Grun J et al. Follistatin antagonizes transforming growth factor-beta3-induced epithelial-mesenchymal transition in vitro: implications for murine palatal development supported by microarray analysis. Differentiation 2008; 76:404-16.
39. Lin SY, Morrison JR, Phillips DJ, de Kretser DM. Regulation of ovarian function by the TGF-beta superfamily and follistatin. Reproduction 2003; 126:133-48.
40. Sugino K, Kurosawa N, Nakamura T et al. Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell. J Biol Chem 1993; 268:15579-87.
41. Hashimoto O, Kawasaki N, Tsuchida K, Shimasaki S, Hayakawa T, Sugino H. Difference between follistatin isoforms in the inhibition of activin signalling: activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin. Cell Signal 2000; 12:565-71.
42. Phillips DJ, Jones KL, McGaw DJ et al. Release of activin and follistatin during cardiovascular procedures is largely due to heparin administration. J Clin Endocrinol Metab 2000; 85:2411-5.
43. Hashimoto O, Nakamura T, Shoji H, Shimasaki S, Hayashi Y, Sugino H. A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate. J Biol Chem 1997; 272:13835-42.
44. Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, Sugino H. Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J Biol Chem 2000; 275:40788-96.
45. Hill JJ, Davies MV, Pearson AA et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 2002; 277:40735-41.
46. Walton KL, Makanji Y, Harrison CA. New insights into the mechanisms of activin action and inhibition. Mol Cell Endocrinol 2012; 359:2-12.
47. de Kretser DM, O'Hehir RE, Hardy CL, Hedger MP. The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair. Mol Cell Endocrinol 2012; 359:101-6.
48. Kariyawasam HH, Semitekolou M, Robinson DS, Xanthou G. Activin-A: a novel critical regulator of allergic asthma. Clin Exp Allergy 2011; 41:1505-14.
49. Hedger MP, Clarke L. Isolation of rat blood lymphocytes using a two-step Percoll density gradient. Effect of activin (erythroid differentiation factor) on peripheral T lymphocyte proliferation in vitro. J Immunol Methods 1993; 163:133-6.
50. Hedger MP, Drummond AE, Robertson DM, Risbridger GP, de Kretser DM. Inhibin and activin regulate [3H]thymidine uptake by rat thymocytes and 3T3 cells in vitro. Mol Cell Endocrinol 1989; 61:133-8.
51. Zipori D, Barda-Saad M. Role of activin A in negative regulation of normal and tumor B lymphocytes. J Leukoc Biol 2001; 69:867-73.
52. Yu EW, Dolter KE, Shao LE, Yu J. Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies. Clin Exp Immunol 1998; 112:126-32.
53. Robson NC, Phillips DJ, McAlpine T et al. Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood 2008; 111:2733-43.
54. Segerer SE, Muller N, Brandt J et al. The glycoprotein-hormones activin A and inhibin A interfere with dendritic cell maturation. Reprod Biol Endocrinol 2008; 6:17.
55. Scutera S, Riboldi E, Daniele R et al. Production and function of activin A in human dendritic cells. Eur Cytokine Netw 2008; 19:60-8.
56. Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL. Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 2008; 8:142-52.
57. Khare A, Krishnamoorthy N, Oriss TB, Fei M, Ray P, Ray A. Cutting edge: inhaled antigen upregulates retinaldehyde dehydrogenase in lung CD103+ but not plasmacytoid dendritic cells to induce Foxp3 de novo in CD4+ T cells and promote airway tolerance. J Immunol 2013; 191:25-9.
58. Lloyd CM, Murdoch JR. Tolerizing allergic responses in the lung. Mucosal Immunol 2010; 3:334-44.
59. Huber S, Stahl FR, Schrader J et al. Activin A promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells. J Immunol 2009; 182:4633-40.
60. Semitekolou M, Alissafi T, Aggelakopoulou M et al. Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J Exp Med 2009; 206:1769-85.
61. Kypriotou M, Rivero D, Haller S et al. Activin a inhibits antigen-induced allergy in murine epicutaneous sensitization. Front Immunol 2013; 4:246.
62. Salogni L, Musso T, Bosisio D et al. Activin A induces dendritic cell migration through the polarized release of CXC chemokine ligands 12 and 14. Blood 2009; 113:5848-56.
63. Vittorakis S, Samitas K, Tousa S et al. Circulating conventional and plasmacytoid dendritic cell subsets display distinct kinetics during in vivo repeated allergen skin challenges in atopic subjects. BioMed Res Int 2014; 2014:231036.
64. Apostolou E, Stavropoulos A, Sountoulidis A et al. Activin-A overexpression in the murine lung causes pathology that simulates acute respiratory distress syndrome. Am J Respir Crit Care Med 2012; 185:382-91.
65. de Kretser DM, Bensley JG, Pettila V et al. Serum activin A and B levels predict outcome in patients with acute respiratory failure: a prospective cohort study. Crit Care 2013; 17:R263.
66. Ogawa K, Funaba M, Tsujimoto M. A dual role of activin A in regulating immunoglobulin production of B cells. J Leukoc Biol. 2008; 83(6):1451-8.
67. Dohi T, Ejima C, Kato R et al. Therapeutic potential of follistatin for colonic inflammation in mice. Gastroenterology 2005; 128:411-23.
68. Jones KL, Mansell A, Patella S et al. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci USA 2007; 104:16239-44.
69. Hardy CL, King SJ, Mifsud NA et al. The activin A antagonist follistatin inhibits cystic fibrosis-like lung inflammation and pathology. Immunol Cell Biol 2015; [Epub 3 March 2015].
70. Gurdon JB, Standley H, Dyson S et al. Single cells can sense their position in a morphogen gradient. Development 1999; 126:5309-17.
71. Wohlfahrt JG, Kunzmann S, Menz G et al. T cell phenotype in allergic asthma and atopic dermatitis. Int Arch Allergy Immunol 2003; 131:272-82.
72. Cho SH, Yao Z, Wang SW et al. Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. J Immunol 2003; 170:4045-52.
73. Chen Y, Wu H, Winnall WR et al. Tumour necrosis factor-alpha stimulates human neutrophils to release preformed activin A. Immunol Cell Biol 2011; 89:889-96.
74. Ohnishi N, Miyata T, Ohnishi H et al. Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis. Gut 2003; 52:1487-93.
75. Wada W, Kuwano H, Hasegawa Y, Kojima I. The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells. Endocrinology 2004; 145:2753-9.
76. Kumar RK, Foster PS. Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 2002; 27:267-72.
77. Le AV, Cho JY, Miller M, McElwain S, Golgotiu K, Broide DH. Inhibition of allergen-induced airway remodeling in Smad 3-deficient mice. J Immunol 2007; 178:7310-6.
78. Von Bubnoff D, Matz H, Cazenave JP, Hanau D, Bieber T, De La Salle H. Kinetics of gene induction after Fc epsilon RI ligation of atopic monocytes identified by suppression subtractive hybridization. J Immunol 2002; 169:6170-7.
79. McMillan SJ, Lloyd CM. Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy 2004; 34:497-507.
80. Magnan A, Retornaz F, Tsicopoulos A et al. Altered compartmentalization of transforming growth factor-beta in asthmatic airways. Clin Exp Allergy 1997; 27:389-95.
81. Rosendahl A, Checchin D, Fehniger TE, ten Dijke P, Heldin CH, Sideras P. Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation. Am J Respir Cell Mol Biol 2001; 25:60-8.
82. Liu M, Subramanian V, Christie C, Castro M, Mohanakumar T. Immune responses to self-antigens in asthma patients: clinical and immunopathological implications. Hum Immunol 2012; 73:511-6.
83. Stumm CL, Halcsik E, Landgraf RG, Camara NO, Sogayar MC, Jancar S. Lung remodeling in a mouse model of asthma involves a balance between TGF-beta1 and BMP-7. PLoS ONE 2014; 9:e95959.
84. Torrego A, Hew M, Oates T, Sukkar M. Fan Chung K. Expression and activation of TGF-beta isoforms in acute allergen-induced remodelling in asthma. Thorax 2007; 62:307-13.
85. Nakao A, Sagara H, Setoguchi Y et al. Expression of Smad7 in bronchial epithelial cells is inversely correlated to basement membrane thickness and airway hyperresponsiveness in patients with asthma. J Allergy Clin Immunol 2002; 110:873-8.
86. Gregory LG, Mathie SA, Walker SA, Pegorier S, Jones CP, Lloyd CM. Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25. Am J Respir Crit Care Med 2010; 182:143-54.
87. Boyce JA, Austen KF. No audible wheezing: nuggets and conundrums from mouse asthma models. J Exp Med 2005; 201:1869-73.
88. Jones CP, Gregory LG, Causton B, Campbell GA, Lloyd CM. Activin A and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol 2012; 129:1000-10 e3.
89. Yamashita S, Maeshima A, Kojima I, Nojima Y. Activin A is a potent activator of renal interstitial fibroblasts. J Am Soc Nephrol 2004; 15:91-101.
90. Matsuse T, Ikegami A, Ohga E et al. Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis. Am J Pathol 1996; 148:707-13.
91. Ohga E, Matsuse T, Teramoto S et al. Effects of activin A on proliferation and differentiation of human lung fibroblasts. Biochem Biophys Res Commun 1996; 228:391-6.
92. Leigh R, Oyelusi W, Wiehler S et al. Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. J Allergy Clin Immunol 2008; 121:1238-45 e4.
93. Wu H, Chen Y, Winnall WR, Phillips DJ, Hedger MP. Acute regulation of activin A and its binding protein, follistatin, in serum and tissues following lipopolysaccharide treatment of adult male mice. Am J Physiol Regul Integr Comp Physiol 2012; 303:R665-75.
94. Hardy CL, Lemasurier JS, Olsson F et al. Interleukin-13 regulates secretion of the tumor growth factor-{beta} superfamily cytokine activin A in allergic airway inflammation. Am J Respir Cell Mol Biol 2010; 42:667-75.
95. Kota J, Handy CR, Haidet AM et al. Follistatin gene delivery enhances muscle growth and strength in nonhuman primates. Sci Transl Med 2009; 1:6ra15.